BCL10GFP can be utilized like a convenient tool for studying the determinants for efficient MALT1 cleavage in HEK293T cells. Competing interests The authors declare that they have no competing interests. Authors’ contributions SYJ carried out the site directed mutagenesis and cleavage assay, drafted the manuscript. Methods Numerous BCL10GFP constructs were transfected into HEK293T cell with MALT1 construct by using calcium phosphate-DNA precipitation method. Lysates of transfectants were resolved by SDS/PAGE and analyzed by western blot analysis. Results BCL10GFP was proteolytically processed by MALT1 as BCL10. The integrity of caspase recruitment website (Cards) and MALT1-interacting website on BCL10 were required for MALT1 proteolytic activity. Besides the invariant P1 cleavage site Arg228, P4 Leu225 played a role in defining BCL10 as a good substrate for MALT1. Conclusions We offered a way of monitoring the catalytic activity of MALT1 in HEK293T cells using BCL10GFP like a substrate. BCL10GFP can be utilized as a easy tool for studying the determinants for efficient MALT1 cleavage in HEK293T cells gene was purchased form Invitrogen (Carlsbad, CA) and utilized as template for building of all the BCL10-derived manifestation vectors. Manifestation vectors pCMV6/XL5/MALT1 (comprising full size MALT1 cDNA) and pCMV6/XL5/IAP2 (Comprising full size IAP2 cDNA) were purchased from ORIGENE Bupropion Systems Inc. (Rockville, Maryland). Please see the supplementary for detailed building info for those BCL10, IAP2-MALT1 and MALT1 constructs. All the constructs were confirmed by sequencing analysis. Mouse anti-BCL10 monoclonal antibody (sc-5273) and mouse anti-MALT1 antibody (sc-46677) were purchased from Santa Cruz Biotchnology (Santa Cruz, CA). Anti-GAPDH antibody (H86504M) was purchased from Biodesign international (Saco, ME). Rabbit polyclonal antibody against GFP indicated in was also generated for detection of green fluorescence protein. Horse radish peroxidase-linked donkey anti-rabbit IgG and sheep anti-mouse IgG were purchased from Amersham Biosciences. Cell Tradition and Transfection HEK293T cells were cultured in DMEM comprising 10% (vol/vol) FBS, 50 devices/ml penicillin, 50 g/ml streptomycin, 1.25 g/ml fungizone (all Bupropion from GIBCO, Invitrogen, Carlsbad, CA) at 37C inside a 5% CO2 incubator. Transfection was performed from the calcium phosphate-DNA precipitation method. Western Blot Bupropion Analysis Cells were rinsed with PBS and lysed with RIPA buffer (150 mM NaCl, 50 mM Tris pH7.5,1% NP40, 0.1% SDS, 1mM EDTA, 1mM PMSF, 1g/ml aprotinin, leupeptin, pepstatin, 1mM Na3VO4, 1mM NaF). Denatured protein were separated on SDS/polyacrylamide gels, transferred MMP3 to Hybond-P membranes (Amersham Biosciences), and subjected to immunoblotting with antibodies indicated. Immunoprecipitation and CIAP Treatment Cells Bupropion were rinsed with PBS and lysed with revised RIPA buffer (150 mM NaCl, 50 mM Tris pH7.5, 1% NP40, 0.25% Sodium deoxycholate, 1mM EDTA, 1mM PMSF, 1mg/ml aprotinin, leupeptin, pepstatin, 1mM Na3VO4, 1mM NaF). 1 mg total cellular protein were incubated with 5 l mouse anti-BCL10 antibody (sc-5273, Santa Crutz Biotchnology) for 16 hr at 4C. 50l protein A beads were then added. The whole mixtures were incubated at 4C for 4 hr. Protein A beads were spun down, washed twice with RIPA buffer and subjected to Calf Intestine Alkaline Phosphatase (CIAP) (New England Biolab.) treatment as suggested from the manufacturers protocol. Protein manifestation and purification pET21aBCL10-His and pET21aBCL10-His mutants were transformed into BL21(DE3) cells. Protein manifestation was induced with 1 mM IPTG (isopropyl -D-thiogalactopyranoside) for 4 hr at 37C. cells were lysed in lysis buffer (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM imidazole, 8 M urea), sonicated. The lysates were centrifuged at 13K rpm (KUBOTA 1920) for 10 min at 4C. The soluble portion was applied to Ni2+ NTA agarose (Qiagen). Purification was performed as the makes instruction. The protein was eluted with 250 mM imidazole. pET21a-MALT1-His or pET21a-MALT1C464A-His was transformed into Arctic-ExpressTM RIL compent cells. Protein manifestation was induced with 1 mM IPTG (isopropyl -D-thiogalactopyranoside) for 48 hr at 8C. cells were suspended in buffer (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM imidazole) and lysed by 700 psi people from france press (Thermo IEC People from france press laboratory with mini pressure cell, 120VAC, 60Hz). The lysates were centrifuged at 13K rpm (KUBOTA 1920) for 10 min at 4C. The soluble portion was applied to Ni2+ NTA Bupropion agarose (Qiagen). The protein was purified according to the produces teaching and eluted with 250 mM imidazole. All the purified proteins were dialyzed against PBS and stored at -70C refrigerator in the presence of 20% glycerol. cleavage assay of purified MALT1 50 ng purified BCL10 or mutant BCL10 proteins were incubated with 1 g or 2 g purified full size MALT1 or catalytic-inactive mutant MALT1C464A respectively for 4.